![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/13 | |
A61K 38/21 | |||
A61P 1/16 | |||
A61P 31/14 |
(11) | Number of the document | 1778272 |
(13) | Kind of document | T |
(96) | European patent application number | 05759733.8 |
Date of filing the European patent application | 2005-07-13 | |
(97) | Date of publication of the European application | 2007-05-02 |
(45) | Date of publication and mention of the grant of the patent | 2011-02-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2005/007633 |
Date | 2005-07-13 |
(87) | Number | WO 2006/005610 |
Date | 2006-01-19 |
(30) | Number | Date | Country code |
04016583 | 2004-07-14 | EP |
(72) |
CORNU-ARTIS, Catherine, FR
VACHON, Guylaine, CH
URYUHARA, Yoko, JP
ASAKAWA, Kazuo, JP
MERTES, Reinhild Elisabeth, DE
YOSHIBA, Shinsyou, JP
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
(54) | USE OF A COMBINATION OF CYCLOSPORIN AND PEGYLATED INTERFERONS FOR TREATING HEPATITIS C (HCV) |
USE OF A COMBINATION OF CYCLOSPORIN AND PEGYLATED INTERFERONS FOR TREATING HEPATITIS C (HCV) |